Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: Implications for multi-threat medical countermeasures

被引:28
作者
Cowan, FM [1 ]
Broomfield, CA [1 ]
Lenz, DE [1 ]
Smith, WJ [1 ]
机构
[1] USA, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA
关键词
organophosphorus; soman toxicity; sulfur mustard toxicity; protease; protease inhibitor; protease activated receptor; adenosine receptor; NMDA receptor; platelet activating factor; inflammation;
D O I
10.1002/jat.901
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Despite the contrasts in chemistry and toxicity, for blister and nerve chemical warfare agents there may be some analogous proteolytic and inflammatory mediators and pathological pathways that can be pharmacological targets for a single-drug multi-threat medical countermeasure. The dermal-epidermal separation caused by proteases and bullous diseases compared with that observed following exposure to the blister agent sulfur mustard (2,2'-dichlorodiethyl sulfide) has fostered the hypothesis that sulfur mustard vesication involves proteolysis and inflammation. In conjunction with the paramount toxicological event of cholinergic crisis that causes acute toxicity and precipitates neuronal degeneration, both anaphylactoid reactions and pathological proteolytic activity have been reported in nerve-agent-intoxicated animals. Two classes of drugs already have demonstrated multi-threat activity for both nerve and blister agents. Serine protease inhibitors can prolong the survival of animals intoxicated with the nerve agent soman and can also protect against vesication caused by the blister agent sulfur mustard. Poly (ADP-ribose) polymerase (PARP) inhibitors can reduce both soman-induced neuronal degeneration and sulfur-mustard-induced epidermal necrosis. Protease and PARP inhibitors, like many of the other countermeasures for blister and nerve agents, have potent primary or secondary anti-inflammatory pharmacology. Accordingly, we hypothesize that drugs with anti-inflammatory actions against either nerve or blister agent might also display multi-threat efficacy for the inflammatory pathogenesis of both classes of chemical warfare agent. Published in 2003 by John Wiley Sons, Ltd.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 106 条
[1]  
ADAMS GK, 1976, EUR J PHARMACOL, V38, P101
[2]   Interaction between neurone and microglia mediated by platelet-activating factor [J].
Aihara, N ;
Ishii, S ;
Kume, K ;
Shimizu, T .
GENES TO CELLS, 2000, 5 (05) :397-406
[3]   Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure [J].
Arroyo, CM ;
Schafer, RJ ;
Kurt, EM ;
Broomfield, CA ;
Carmichael, AJ .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1999, 18 (01) :1-11
[4]   ACTIVATION OF ALPHA-HUMAN TUMOR-NECROSIS-FACTOR (TNF-ALPHA) BY HUMAN MONOCYTES (THP-1) EXPOSED TO 2-CHLOROETHYL ETHYL SULFIDE (H-MG) [J].
ARROYO, CM ;
VONTERSCH, RL ;
BROOMFIELD, CA .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1995, 14 (07) :547-553
[5]   PROTEINASES AND PROTEINASE INHIBITORS IN EXPERIMENTAL SHOCK STATES [J].
BACK, N ;
WILKENS, H ;
STEGER, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 146 (A2) :491-+
[6]  
Bal-Price A, 2001, J NEUROSCI, V21, P6480
[7]  
Bazan NG, 1998, PROG BRAIN RES, V118, P281
[8]   MEDIATORS OF INJURY IN NEUROTRAUMA - INTRACELLULAR SIGNAL-TRANSDUCTION AND GENE-EXPRESSION [J].
BAZAN, NG ;
DETURCO, EBR ;
ALLAN, G .
JOURNAL OF NEUROTRAUMA, 1995, 12 (05) :791-814
[9]   Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression [J].
Bazan, NG ;
Allan, G .
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1996, 14 (1-3) :321-330
[10]   Platelet activating factor receptor expression is associated with neuronal apoptosis in an in vivo model of excitotoxicity [J].
Bennett, SAL ;
Chen, JH ;
Pappas, BA ;
Roberts, DCS ;
Tenniswood, M .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (10) :867-875